Apellis Pharmaceuticals Inc XNAS: APLS

Mid-range Performer

Download real time

20.33 0.52 (2.62%)

43.09% Fall from 52W High

2.5M

XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Apellis Pharmaceuticals Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents